ANNUAL REPORT 2002
|
|
|
|
|
 |
|
| |
|
| Common Stock |
|
|
|
Capital in
Excess of
Par Value |
|
Contributed
Capital |
|
Notes
Receivable |
|
Accumulated
Deficit |
|
Total
Stockholders'
Equity |
| Class A |
|
Class B |
| |
Shares |
|
Amount |
|
Shares |
|
Amount |
|
|
|
|
|
|
|
|
|
|
| |
(In thousands, except share and per share data) |
| |
| Balance at October 31, 1999 |
22,280,867 |
223 |
117.7 |
--- |
282,054 |
24,574 |
(2,463) |
(250,351) |
54,037 |
Exercise of stock options and
warrants |
92,128 |
|
|
|
577 |
|
|
|
577 |
| Sale of common stock |
2,565,000 |
26 |
|
|
83,725 |
|
|
|
83,751 |
| Equity compensation |
|
|
|
|
3,681 |
|
|
|
3,681 |
Payment of discount plus
interest on "non-lapse"
restricted shares |
|
|
|
|
2,112 |
|
|
|
2,112 |
Payment of notes receivable
from shareholders |
|
|
|
|
|
|
556 |
|
556 |
| Accrued interest |
|
|
|
|
|
|
(126) |
|
(126) |
| Net loss |
|
|
|
|
|
|
|
(36,078) |
(36,078) |
|
|
|
|
|
|
|
|
|
|
| Balance at October 31, 2000 |
24,937,995 |
249 |
117.7 |
--- |
372,149 |
24,574 |
(2,033) |
(286,429) |
108,510 |
Exercise of stock options and
warrants |
226,550 |
2 |
|
|
1,929 |
|
|
|
1,931 |
Stock issued for acquisition
of research and
development information |
67,270 |
|
|
|
1,511 |
|
|
|
1,511 |
Land acquired upon exercise
of stock option |
80,000 |
1 |
|
|
1,004 |
|
|
|
1,005 |
Retirement of treasury stock
that resulted from payment
of "non-lapse" restricted
shares |
(86,732) |
--- |
|
|
--- |
|
|
|
|
| Equity compensation |
|
|
|
|
6,844 |
|
|
|
6,844 |
Payment of discount plus
interest"on non-lapse"
restricted shares |
|
|
|
|
133 |
|
|
|
133 |
Payment of notes receivable
from shareholders |
|
|
|
|
|
|
468 |
|
468 |
| Accrued interest |
|
|
|
|
|
|
(90) |
|
(90) |
| Net loss |
|
|
|
|
|
|
|
(49,419) |
(49,419) |
|
|
|
|
|
|
|
|
|
|
| Balance at October 31, 2001 |
25,225,083 |
$252 |
117.7 |
--- |
$383,570 |
$24,574 |
$(1,655) |
$(335,848) |
$ 70,893 |
Exercise of stock options and
warrants |
2,842 |
--- |
|
|
40 |
|
|
|
40 |
| Sale of common stock |
5,121,297 |
52 |
|
|
35,382 |
|
|
|
35,434 |
Adjustment for stock issued
for acquisition of research
and development
information |
(3,852) |
--- |
|
|
|
|
|
|
--- |
Land acquired upon exercise
of stock option |
8,000 |
--- |
|
|
134 |
|
|
|
134 |
| Equity compensation |
|
|
|
|
(61) |
|
|
|
(61) |
Payment of notes receivable
from shareholders |
|
|
|
|
|
|
80 |
|
80 |
Settlement of note receivable
and accrued interest from
shareholder |
|
|
|
|
|
|
1,601 |
|
1,601 |
Amended note receivable to
shareholder |
|
|
|
|
|
|
(233) |
|
(233) |
| Accrued interest |
|
|
|
|
|
|
(48) |
|
(48) |
| Net loss |
|
|
|
|
|
|
|
(45,783) |
(45,783) |
|
|
|
|
|
|
|
|
|
|
| Balance at October 31, 2002 |
30,353,370 |
$304 |
117.7 |
$ --- |
$419,065 |
$24,574 |
$ (255) |
$(381,631) |
$ 62,057 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes.
|
|
|
|